News

ProCure Proton Therapy Advocates for Early Breast Cancer Awareness

ProCure Proton Therapy Advocates for Early Breast Cancer Awareness

ProCure Proton Therapy Center's Call to Action

ProCure Proton Therapy Center is making a significant appeal to news organizations to help improve awareness regarding early breast cancer detection and effective treatment options. This need is underscored by alarming statistics: one in eight women will face a breast cancer diagnosis in their lifetime. With proactive measures and early intervention, studies show that the survival rate can reach an impressive 99%.

Importance of Early Detection

Brian Chon, M.D., Medical Director at ProCure, emphasizes the life-saving potential of breast cancer screening. He states, "Breast cancer screening saves lives." During the awareness month dedicated to this critical health issue, he urges media representatives to join in amplifying the message about early detection's vital role in ensuring favorable treatment outcomes. The earlier cancer is detected, the more options a patient might have, including less aggressive treatment protocols that promote a better quality of life.

Proton Therapy: A Groundbreaking Treatment Option

For numerous women battling breast cancer, radiation therapy becomes an essential part of their treatment plan. Among the options, proton therapy stands out as a targeted and effective choice, minimizing radiation exposure to vital organs such as the heart and lungs. By doing so, patients can reduce their risk of experiencing adverse effects, which may include heart disease.

Accessibility of Treatment

Many individuals are unaware that proton therapy is more accessible than they might think. With ProCure's treatment facility located in Somerset, New Jersey, the center is easily reachable for residents of the New York and Philadelphia metropolitan areas. ProCure collaborates with numerous insurance providers, ensuring that financial hurdles do not prevent individuals from accessing critical care and treatment.

Expert Guidance and Education

Dr. Chon, alongside his team of dedicated physicians at ProCure, stands ready to assist journalists and media outlets seeking further information or insights into the importance of breast cancer detection and treatment. Their expertise can help shed light on the significant strides being made in cancer treatment, particularly with proton therapy.

About ProCure Proton Therapy Center

Established in March 2012, ProCure Proton Therapy Center is recognized as the first proton therapy facility in the tri-state area. It has been successful in treating various cancers, including breast, prostate, lung, brain, and gastrointestinal cancers. With over 7,400 patients treated, including more than 750 pediatric cases, ProCure aims to provide personalized treatment options that prioritize patients’ medical needs while minimizing side effects and recovery time. This focus allows patients to continue enjoying their lives, engaging in activities they love.

Media Inquiries

For media-related inquiries, you can reach out to Sarah Ferrington, Marketing Manager at ProCure. Here are her contact details:

Phone: 732-357-2609

Email: [Contact information withheld for privacy]

Frequently Asked Questions

What is proton therapy?

Proton therapy is a targeted radiation treatment that uses protons to treat cancer while minimizing damage to surrounding healthy tissues.

Why is early detection of breast cancer important?

Early detection often leads to better treatment outcomes and increases the chances of survival, allowing for less aggressive treatment.

How accessible is proton therapy?

Proton therapy is available at several locations, including ProCure's Somerset center, which is easily reachable from nearby major cities.

What types of cancer can ProCure treat?

ProCure treats a range of cancers, including those of the breast, prostate, lung, brain, and gastrointestinal system, among others.

How does ProCure assist with financial aspects of treatment?

ProCure collaborates with various insurance plans and provides dedicated staff to help patients navigate their financial options.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 268

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 186

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 183

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 174

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 170

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 281

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 224

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 225

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 92

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading

Top 5 Most Recently Viewed Articles

Paratus Welcomes New Chief Commercial Officer for Growth

Updated Category News Views 291

Paratus Strengthens Leadership with New Appointment In a significant strategic move, Paratus Holdings Limited has appointed Taraneh Azad as their new Chief Commercial Officer. This decision comes as the company aims to refine its commercial strategy while forming vital partnerships across various sectors. Meet Taraneh Azad Taraneh Azad is a well-respected figure in the...

Continue Reading
Banco Comercial Português Updates on Share Buy-Back Programme

Updated Category News Views 186

Banco Comercial Português Announces Share Buy-Back Programme Report Banco Comercial Português, S.A. has provided an important update regarding its Share Buy-Back Programme. This report highlights the activities undertaken within the scope of the program, reflecting the bank's ongoing commitment to enhancing shareholder value. Understanding the Share Buy-Back Programme...

Continue Reading
Unitil Enhances Operations with Bangor Natural Gas Acquisition

Updated Category News Views 220

Unitil Completes Strategic Acquisition of Bangor Natural Gas Unitil Corporation (NYSE:UTL) has taken a significant step in strengthening its position in the energy sector by completing the purchase of Bangor Natural Gas Company. The successful acquisition, concluded recently, paves the way for Unitil to increase its customer base and enhance service delivery across the...

Continue Reading
ISS A/S Announces Strategic Share Buyback Details

Updated Category News Views 92

Overview of Share Buyback Programme ISS A/S, a prominent player in workplace experience and facility management, recently revealed significant updates regarding its share buyback programme. Following an earlier announcement regarding this initiative, ISS A/S plans to redistribute excess cash back to its loyal shareholders. This strategy aligns with their goal to reduce...

Continue Reading
bluebird bio Enhances Access to Gene Therapy with CMMI Agreement

Updated Category News Views 325

bluebird bio and CMMI: A New Era in Gene Therapy Access bluebird bio, Inc. (NASDAQ: BLUE) is making notable strides in the field of gene therapy as it has recently entered into a significant partnership with the Center for Medicare and Medicaid Innovation (CMMI). This collaboration aims to enhance the accessibility of LYFGENIA, a gene therapy specifically designed for...

Continue Reading